William Mallet
10Patents
3h-index
17Co-inventors
53Inventor score
Filing activity: Jun 14, 2006 → Jun 4, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7723485B2 | Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates | Chemistry; Metallurgy | 132 | Active |
| US7989595B2 | Compositions and methods for the diagnosis and treatment of tumor | Emerging Cross-Sectional Technologies | 16 | Active |
| US9056910B2 | Anti-PMEL17 antibodies and immunoconjugates | Chemistry; Metallurgy | 11 | Active |
| US10786578B2 | CKIT antibody drug conjugates | Chemistry; Metallurgy | 2 | Active |
| US9597411B2 | Anti-PMEL17 antibodies and immunoconjugates | Chemistry; Metallurgy | 1 | Active |
| US8449883B2 | Compositions and methods for the diagnosis and treatment of tumor | Emerging Cross-Sectional Technologies | 1 | Active |
| US10196454B2 | Anti-PMEL17 antibodies and immunoconjugates | Chemistry; Metallurgy | 1 | Active |
| USRE47223E1 | Compositions and methods for the diagnosis and treatment of tumor | General | 0 | Active |
| US11833215B2 | CKIT antibody drug conjugates | Chemistry; Metallurgy | 0 | Active |
| USRE47194E1 | Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates | General | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.